Aligos Therapeutics, Inc.
ALGSNasdaqCIK 1799448HealthcareFiscal year ends Dec 31
Reports and events: 99 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1516:03 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-391880 |
| 2026-08-0608:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-336851 |
| 2026-08-0608:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005294 |
| 2026-06-2616:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-285426 |
| 2026-06-2416:30 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-281134 |
| 2026-05-0716:18 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-212001 |
| 2026-05-0716:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003156 |
| 2026-04-2916:25 ET | DEF 14A | Proxy statementPeriod 2026-06-25 | 0001193125-26-191843 |
| 2026-04-2116:32 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-166987 |
| 2026-04-1416:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-154927 |
| 2026-03-0508:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-092614 |
| 2026-03-0508:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001340 |
| 2026-02-0416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-037558 |
| 2025-11-0608:37 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-268203 |
| 2025-11-0608:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-007075 |
| 2025-08-0616:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104042 |
| 2025-08-0616:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005116 |
| 2025-06-2616:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-148905 |
| 2025-05-0608:14 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-063983 |
| 2025-05-0608:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002781 |
| 2025-04-2816:05 ET | DEF 14A | Proxy statementPeriod 2025-06-25 | 0001193125-25-100453 |
| 2025-03-1220:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-038262 |
| 2025-03-1008:07 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-035929 |
| 2025-03-1008:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001352 |
| 2025-02-1208:52 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-024838 |
| 2025-02-0316:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-019256 |
| 2024-11-0616:24 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122371 |
| 2024-11-0616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006057 |
| 2024-09-0516:06 ET | 8-K | 8.01 Other events | 0001193125-24-214188 |
| 2024-08-1916:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-202813 |
| 2024-08-0816:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-196966 |
| 2024-08-0616:14 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091828 |
| 2024-08-0616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004482 |
| 2024-06-2816:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-172218 |
| 2024-05-3116:05 ET | 8-K | 3.01 Delisting notice | 0001193125-24-151729 |
| 2024-05-2216:02 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001193125-24-144929 |
| 2024-05-1517:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-139476 |
| 2024-05-0716:13 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-054497 |
| 2024-05-0716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002612 |
| 2024-04-2916:00 ET | DEF 14A | Proxy statementPeriod 2024-06-27 | 0001193125-24-122181 |
| 2024-03-1216:15 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-029953 |
| 2024-03-1216:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-001294 |
| 2024-02-2817:28 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-050987 |
| 2024-02-0817:44 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-028548 |
| 2024-01-2506:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-014769 |
| 2023-11-2216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-282236 |
| 2023-11-1516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-277877 |
| 2023-11-0616:05 ET | SC 13D | Ownership report, active investor | 0001193125-23-271361 |
| 2023-11-0216:23 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-058256 |
| 2023-11-0216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006671 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.